Omkar Pharmachem Ltd - Stock Valuation and Financial Performance

BSE: 532167 | NSE: | Pharmaceuticals & Drugs | Small Cap

Omkar Pharmachem Share Price

28.99 0.00 0.00%
as on 27-Nov'24 16:59

DeciZen - make an informed investing decision on Omkar Pharmachem

M-Cap below 100cr DeciZen not available

Omkar Pharmachem stock performance -

mw4me loader
P/E Ratio (SA):
155.51
Market Cap:
29.2 Cr.
52-wk low:
21.5
52-wk high:
29

Is Omkar Pharmachem Ltd an attractive stock to invest in?

1. Is Omkar Pharmachem Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Omkar Pharmachem Ltd is a below average quality company.

2. Is Omkar Pharmachem Ltd undervalued or overvalued?

The key valuation ratios of Omkar Pharmachem Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Omkar Pharmachem Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Omkar Pharmachem Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Omkar Pharmachem:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Omkar Pharmachem Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % -0.7%-1.3%2.9%-2.6%-4.1%-2.2%0.2%2.8%3.2%2.9%-
Value Creation
Index
-1.1-1.1-0.8-1.2-1.3-1.2-1.0-0.8-0.8-0.8-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 000000.10.30.50.50.50
Sales YoY Gr.-NANANANANA440%100%0%0%-
Adj EPS -0.1-0.1-0.1-0.3-0.4-0.30.20.20.20.20.2
YoY Gr.-NANANANANANA-18.2%11.1%-5%-
BVPS (₹) 9.29.19.39.18.68.48.68.899.29.3
Adj Net
Profit
-0.1-0.1-0.1-0.3-0.4-0.30.20.20.20.20
Cash Flow from Ops. -0.10.3-0.8-0.3-0.3-0.200.20.30.3-
Debt/CF from Ops. -0.300-1-1.9-4.140.34.62.31-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA26%0%
Adj EPS NANA-4.8%-5%
BVPS-0.1%1.2%2.2%2.1%
Share Price 16.9% 13.6% 8.6% 33.1%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
-0.7-1.3-1.3-2.8-4.7-32.62.12.22.12.1
Op. Profit
Mgn %
00000-454.28.149.857.652.5NAN
Net Profit
Mgn %
00000-576.98233.936.635INF
Debt to
Equity
00000.10.10.10.10.100
Working Cap
Days
0000073303771820
Cash Conv.
Cycle
0000010-43-18-12-30

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 25.99%

Return on Equity has declined versus last 3 years average to 2.10%

Net Profit has been subdued in last 3 years -4.77%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Omkar Pharmachem Ltd.

Standalone Consolidated
TTM EPS (₹) 0.2 -
TTM Sales (₹ Cr.) 0 -
BVPS (₹.) 9.3 -
Reserves (₹ Cr.) -1 -
P/BV 3.12 -
PE 155.51 -
From the Market
52 Week Low / High (₹) 21.50 / 28.99
All Time Low / High (₹) 1.50 / 28.99
Market Cap (₹ Cr.) 29.2
Equity (₹ Cr.) 10.1
Face Value (₹) 10
Industry PE 44.3

Management X-Ray of Omkar Pharmachem:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Omkar Pharmachem

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales000000.050.270.540.540.54
Operating Expenses 0.060.120.220.240.380.250.250.270.230.26
Manufacturing Costs0000000000
Material Costs0000000000
Employee Cost 0.020.030.140.140.190.150.150.170.140.16
Other Costs 0.040.090.080.100.190.100.100.100.090.10
Operating Profit -0.06-0.12-0.22-0.24-0.38-0.200.020.270.310.28
Operating Profit Margin (%) ------454.0%8.1%49.8%57.6%52.5%
Other Income 000.010000000
Interest 0000.010.040.050.060.060.050.03
Depreciation 0000000000
Exceptional Items 000.480000000
Profit Before Tax -0.06-0.120.27-0.25-0.42-0.26-0.040.210.260.25
Tax 000.05000-0.260.030.070.06
Profit After Tax -0.06-0.120.22-0.26-0.42-0.260.220.180.200.19
PAT Margin (%) ------576.0%82.0%33.9%36.6%35.0%
Adjusted EPS (₹)-0.1-0.10.2-0.3-0.4-0.30.20.20.20.2
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 9.279.169.389.128.708.448.668.859.049.23
Share Capital 10.0810.0810.0810.0810.0810.0810.0810.0810.0810.08
Reserves -0.81-0.93-0.71-0.96-1.38-1.64-1.42-1.24-1.04-0.85
Minority Interest0000000000
Debt0.01000.240.580.870.900.930.620.30
Long Term Debt0.01000000000
Short Term Debt0000.240.580.870.900.930.620.30
Trade Payables0.020.040.030.020.020.030.030.020.040.02
Others Liabilities 0.100.520.020.020.020.02-0.22-0.20-0.14-0.06
Total Liabilities 9.409.729.439.409.329.369.379.609.579.49

Fixed Assets

Gross Block0.010.010.010.010.010.010.010.020.020.03
Accumulated Depreciation00000.010.010.010.010.020.02
Net Fixed Assets0.010.0100.010000.0100.01
CWIP 0000000000
Investments 9.309.309.309.309.309.309.309.309.309.30
Inventories0000000000
Trade Receivables0.070.070.070.0700.020.030.080.130.05
Cash Equivalents 00.330.050.020.020.040.040.210.130.07
Others Assets0.01000000000.06
Total Assets 9.409.729.439.409.329.369.379.609.579.49

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity -0.050.34-0.77-0.25-0.30-0.210.020.200.280.30
PBT -0.06-0.12-0.21-0.25-0.42-0.26-0.040.210.260.25
Adjustment 0000.020.120.050.060.060.050.03
Changes in Working Capital 0.010.46-0.51-0.010.01-0.010-0.07-0.040.01
Tax Paid 00-0.050000000
Cash Flow From Investing Activity 000.49-0.01000-0.010-0.01
Capex 000.49-0.01000-0.010-0.01
Net Investments 0000000000
Others 0000000000
Cash Flow From Financing Activity 0-0.010.010.230.300.24-0.02-0.03-0.35-0.35
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid 000.01-0.01-0.04-0.05-0.06-0.06-0.05-0.03
Dividend Paid 0000000000
Others 0-0.0100.240.340.290.040.03-0.31-0.32
Net Cash Flow -0.050.33-0.28-0.0300.0200.17-0.08-0.06
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)-0.66-1.272.38-2.77-4.72-3.032.592.092.212.07
ROCE (%)-0.66-1.272.91-2.55-4.11-2.220.222.763.22.94
Asset Turnover Ratio0000000.030.060.060.06
PAT to CFO Conversion(x)N/AN/A-3.5N/AN/AN/A0.091.111.41.58
Working Capital Days
Receivable Days0000014630377160
Inventory Days0000000000
Payable Days0000000000

Omkar Pharmachem Ltd Stock News

Omkar Pharmachem Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Omkar Pharmachem on 27-Nov-2024 16:59 is ₹28.99.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 27-Nov-2024 16:59 the market cap of Omkar Pharmachem stood at ₹29.24.
The latest P/E ratio of Omkar Pharmachem as of 27-Nov-2024 16:59 is 155.5.
The latest P/B ratio of Omkar Pharmachem as of 27-Nov-2024 16:59 is 3.12.
The 52-week high of Omkar Pharmachem is ₹28.99 and the 52-week low is ₹21.50.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Omkar Pharmachem is ₹0.00 ( Cr.) .

About Omkar Pharmachem Ltd

Omkar Pharmachem was incorporated in 1994, it is located in New Delhi. The manufacturing unit developed the capacity to manufacture sodium bi-sulphite, sodium meta bi-sulphite, sodium sulphite, and sulphur.

In the financial year 2007, the company did not conduct any manufacturing or other business activity due to tough market conditions. It has further decided to discontinue commercial activity and wait till an appropriate business environment is established.

The registered office of the company is located at Mahakant Building, 501, Ashram Road opposite V S Hospital Ellisbridge Ahmedabad, Gujarat 380006.

Business area of the company

The company is engaged in the manufacturing of pharmaceutical chemicals.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.